Skip to main content
    C

    Cingulate Inc (CING)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.72
    +0.97 (+25.87%)

    Market Cap: $62.53M

    Last updated: Nov 17, 2026 at 4:42 PM ET

    Cingulate Inc (CING) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Cingulate (CING) has a market cap of $62.53M and an enterprise value of $42.72M. Its share count is up 167.84% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 31.69% below the market cap, as cash exceeds debt.

    Market Cap$62.53M
    Enterprise Value$42.72M
    Latest price (Nov 17, 2026)$4.72

    Key Dates

    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 10.32% in the quarter ended Sep 30, 2026 and grew 186.98% a year over 2 years.

    Shares Outstanding14.55M
    Shares Change (YoY)+167.84%
    Shares Change (QoQ)+10.32%
    Share Count Growth (2Y CAGR)+186.98%

    Price Statistics

    The stock is up 35.24% over 52 weeks and trades 2.07% below its 50-day average.

    Beta (1Y)1.24
    52-Week Change+35.24%
    1-Month Change+8.26%
    3-Month Change-10.44%
    6-Month Change+7.52%
    Total Return (1Y)+35.24%
    Total Return (3Y CAGR)-59.67%
    Return vs SPY (1Y)+28.09%
    Max Drawdown (1Y)-69.13%
    Max Drawdown (3Y)-98.43%
    Sharpe Ratio (1Y)0.37
    Correlation with SPY (1Y)0.19
    50-Day Average$4.82
    200-Day Average$5.37
    52-Week Range$3.16 to $11.89
    RSI (14 Days)51.3
    Average Volume (20 Days)226.89K

    Price chart

    Financial Position

    Current assets cover 3.90x current liabilities, and total debt is 0.16x shareholder equity.

    Current Ratio3.90x
    Quick Ratio3.90x
    Debt / Equity0.16x

    Returns and Efficiency

    Return on Capital Employed (ROCE)-127.62%
    ROIC (5Y Average)182.57%

    Scores

    CING has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit$419.06K
    Operating Income-$26.42M
    Pretax Income-$29.19M
    Net Income-$29.19M
    EBIT-$27.65M
    Reported EPS (TTM)-$2.77

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 73.78% of the $28.15M in total assets.

    Cash and Equivalents$23.19M
    Total Debt$3.37M
    Net Cash$19.81M
    Net Cash Per Share$1.36
    Working Capital$18.83M
    Shareholder Equity$20.77M
    Book Value Per Share$1.43
    Total Assets$28.15M
    Total Liabilities$7.38M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $367.66K of capital spending, operating cash flow left -$24.16M of free cash flow.

    Operating Cash Flow-$23.79M
    Capital Expenditures$367.66K
    Free Cash Flow-$24.16M
    FCF Per Share-$1.66
    Depreciation and Amortization$393.54K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Stock Splits

    The last split was a 1-for-12 reverse split on Aug 9, 2024.

    Last Split DateAug 9, 2024
    Split TypeReverse split
    Split Ratio1:12

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About CING

    What is CING's market cap?

    Cingulate has a market cap of $62.53M. Its enterprise value, which adds debt and subtracts cash, is $42.72M.

    How many shares of CING are outstanding?

    Cingulate has 14.55M shares outstanding. The count is up 167.84% from a year earlier.

    Does CING pay a dividend?

    No. Cingulate does not pay a dividend.

    How much debt does CING have?

    Cingulate has $3.37M of total debt and $23.19M of cash and equivalents, a net cash position of $19.81M.